vs
Side-by-side financial comparison of Neuronetics, Inc. (STIM) and TREACE MEDICAL CONCEPTS, INC. (TMCI). Click either name above to swap in a different company.
TREACE MEDICAL CONCEPTS, INC. is the larger business by last-quarter revenue ($62.5M vs $41.8M, roughly 1.5× Neuronetics, Inc.). TREACE MEDICAL CONCEPTS, INC. runs the higher net margin — -15.0% vs -17.2%, a 2.2% gap on every dollar of revenue. On growth, Neuronetics, Inc. posted the faster year-over-year revenue change (85.7% vs -9.0%). Neuronetics, Inc. produced more free cash flow last quarter ($692.0K vs $-10.4M). Over the past eight quarters, Neuronetics, Inc.'s revenue compounded faster (54.9% CAGR vs 10.6%).
Neuronetics is a Malvern, PA based, publicly traded company incorporated in Delaware in April 2003, that develops non-invasive treatments for psychiatric disorders that have shown resistance or lack of improvement using traditional medicine. The treatments are based upon neuromodulation technology.
Treace Medical Concepts, Inc. is a medical device company, headquartered in Ponte Vedra Beach, Florida, specializing in the design, manufacture, and marketing of foot and ankle surgical devices and biologics. Lapiplasty, Treace’s novel primary surgical product, advanced the treatment of bunions, surgically correcting the metatarsal bone, for the first time, in all three dimensions.
STIM vs TMCI — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $41.8M | $62.5M |
| Net Profit | $-7.2M | $-9.4M |
| Gross Margin | 52.0% | 80.6% |
| Operating Margin | -12.1% | -9.5% |
| Net Margin | -17.2% | -15.0% |
| Revenue YoY | 85.7% | -9.0% |
| Net Profit YoY | 43.2% | -1775.0% |
| EPS (diluted) | $-0.10 | $-0.14 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $41.8M | $62.5M | ||
| Q3 25 | $37.3M | $50.2M | ||
| Q2 25 | $38.1M | $47.4M | ||
| Q1 25 | $32.0M | $52.6M | ||
| Q4 24 | $22.5M | $68.7M | ||
| Q3 24 | $18.5M | $45.1M | ||
| Q2 24 | $16.4M | $44.5M | ||
| Q1 24 | $17.4M | $51.1M |
| Q4 25 | $-7.2M | $-9.4M | ||
| Q3 25 | $-9.0M | $-16.3M | ||
| Q2 25 | $-10.1M | $-17.4M | ||
| Q1 25 | $-12.7M | $-15.9M | ||
| Q4 24 | $-12.7M | $-501.0K | ||
| Q3 24 | $-13.3M | $-15.4M | ||
| Q2 24 | $-9.8M | $-21.2M | ||
| Q1 24 | $-7.9M | $-18.7M |
| Q4 25 | 52.0% | 80.6% | ||
| Q3 25 | 45.9% | 79.1% | ||
| Q2 25 | 46.6% | 79.7% | ||
| Q1 25 | 49.2% | 79.7% | ||
| Q4 24 | 66.2% | 80.7% | ||
| Q3 24 | 75.6% | 80.1% | ||
| Q2 24 | 74.0% | 80.2% | ||
| Q1 24 | 75.1% | 80.2% |
| Q4 25 | -12.1% | -9.5% | ||
| Q3 25 | -19.6% | -31.2% | ||
| Q2 25 | -21.1% | -35.8% | ||
| Q1 25 | -34.4% | -29.6% | ||
| Q4 24 | -51.0% | -0.3% | ||
| Q3 24 | -41.7% | -33.6% | ||
| Q2 24 | -51.7% | -48.1% | ||
| Q1 24 | -39.4% | -37.1% |
| Q4 25 | -17.2% | -15.0% | ||
| Q3 25 | -24.3% | -32.4% | ||
| Q2 25 | -26.6% | -36.7% | ||
| Q1 25 | -39.6% | -30.3% | ||
| Q4 24 | -56.4% | -0.7% | ||
| Q3 24 | -72.0% | -34.1% | ||
| Q2 24 | -59.8% | -47.7% | ||
| Q1 24 | -45.2% | -36.5% |
| Q4 25 | $-0.10 | $-0.14 | ||
| Q3 25 | $-0.13 | $-0.26 | ||
| Q2 25 | $-0.15 | $-0.28 | ||
| Q1 25 | $-0.21 | $-0.25 | ||
| Q4 24 | $-0.34 | $-0.01 | ||
| Q3 24 | $-0.44 | $-0.25 | ||
| Q2 24 | $-0.33 | $-0.34 | ||
| Q1 24 | $-0.27 | $-0.30 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $28.1M | $48.4M |
| Total DebtLower is stronger | $65.8M | $55.6M |
| Stockholders' EquityBook value | $22.4M | $87.3M |
| Total Assets | $141.6M | $190.6M |
| Debt / EquityLower = less leverage | 2.94× | 0.64× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $28.1M | $48.4M | ||
| Q3 25 | $28.0M | $57.4M | ||
| Q2 25 | $11.0M | $69.3M | ||
| Q1 25 | $20.2M | $76.1M | ||
| Q4 24 | $18.5M | $75.7M | ||
| Q3 24 | $20.9M | $82.8M | ||
| Q2 24 | $42.6M | $95.0M | ||
| Q1 24 | $47.7M | $110.0M |
| Q4 25 | $65.8M | $55.6M | ||
| Q3 25 | $65.7M | $53.5M | ||
| Q2 25 | $55.5M | $53.5M | ||
| Q1 25 | $55.3M | $53.4M | ||
| Q4 24 | $55.2M | $53.3M | ||
| Q3 24 | $46.0M | $53.2M | ||
| Q2 24 | $59.8M | $53.2M | ||
| Q1 24 | $59.4M | $53.1M |
| Q4 25 | $22.4M | $87.3M | ||
| Q3 25 | $27.4M | $89.2M | ||
| Q2 25 | $27.1M | $97.6M | ||
| Q1 25 | $35.5M | $105.3M | ||
| Q4 24 | $27.7M | $112.9M | ||
| Q3 24 | $9.4M | $104.9M | ||
| Q2 24 | $19.4M | $112.1M | ||
| Q1 24 | $27.7M | $126.4M |
| Q4 25 | $141.6M | $190.6M | ||
| Q3 25 | $145.5M | $196.6M | ||
| Q2 25 | $134.7M | $206.4M | ||
| Q1 25 | $142.0M | $205.8M | ||
| Q4 24 | $140.9M | $217.1M | ||
| Q3 24 | — | $212.9M | ||
| Q2 24 | $96.8M | $226.1M | ||
| Q1 24 | $103.8M | $242.7M |
| Q4 25 | 2.94× | 0.64× | ||
| Q3 25 | 2.40× | 0.60× | ||
| Q2 25 | 2.05× | 0.55× | ||
| Q1 25 | 1.56× | 0.51× | ||
| Q4 24 | 1.99× | 0.47× | ||
| Q3 24 | 4.90× | 0.51× | ||
| Q2 24 | 3.08× | 0.47× | ||
| Q1 24 | 2.15× | 0.42× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $908.0K | $-8.0M |
| Free Cash FlowOCF − Capex | $692.0K | $-10.4M |
| FCF MarginFCF / Revenue | 1.7% | -16.7% |
| Capex IntensityCapex / Revenue | 0.5% | 3.8% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-21.2M | $-29.5M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $908.0K | $-8.0M | ||
| Q3 25 | $-785.0K | $-9.1M | ||
| Q2 25 | $-3.5M | $-3.0M | ||
| Q1 25 | $-17.0M | $4.2M | ||
| Q4 24 | $-8.6M | $-4.2M | ||
| Q3 24 | $-5.4M | $-11.8M | ||
| Q2 24 | $-5.0M | $-13.9M | ||
| Q1 24 | $-12.0M | $-7.2M |
| Q4 25 | $692.0K | $-10.4M | ||
| Q3 25 | $-899.0K | $-11.9M | ||
| Q2 25 | $-3.8M | $-7.8M | ||
| Q1 25 | $-17.2M | $655.0K | ||
| Q4 24 | $-8.7M | $-7.3M | ||
| Q3 24 | $-5.8M | $-14.7M | ||
| Q2 24 | $-5.6M | $-15.6M | ||
| Q1 24 | $-12.4M | $-11.1M |
| Q4 25 | 1.7% | -16.7% | ||
| Q3 25 | -2.4% | -23.7% | ||
| Q2 25 | -9.9% | -16.5% | ||
| Q1 25 | -53.8% | 1.2% | ||
| Q4 24 | -38.6% | -10.6% | ||
| Q3 24 | -31.3% | -32.6% | ||
| Q2 24 | -34.0% | -35.2% | ||
| Q1 24 | -71.1% | -21.8% |
| Q4 25 | 0.5% | 3.8% | ||
| Q3 25 | 0.3% | 5.6% | ||
| Q2 25 | 0.7% | 10.1% | ||
| Q1 25 | 0.7% | 6.7% | ||
| Q4 24 | 0.4% | 4.5% | ||
| Q3 24 | 2.1% | 6.4% | ||
| Q2 24 | 3.7% | 3.9% | ||
| Q1 24 | 2.2% | 7.7% |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
